Back to Cardiology
Cardiologyv2017Evidence-Based

Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid

Rules out acute coronary syndrome using high-sensitivity cardiac troponin T and clinical factors. Provides risk stratification for patients presenting with chest pain to the emergency department.

Clinical Input Parameters

ng/L
Range: 0 — 10000 ng/L
Clinical Assessment
Awaiting Parameters
acs probability
—probability
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Probabilistic model using logistic regression incorporating high-sensitivity cardiac troponin T concentration and clinical risk factors

Clinical Pearls & Practice Notes

  • Designed for use in emergency department patients presenting with chest pain suspicious for ACS
  • Uses only high-sensitivity cardiac troponin T (hs-cTnT) as biomarker, not serial measurements
  • Approximately 40% of patients can be classified as very low risk with <1% probability of ACS
  • Validated for use with point-of-care cardiac troponin assays
  • Should be used in conjunction with clinical judgment and appropriate safety netting
  • Not applicable to patients with STEMI or obvious ACS on presentation
  • Requires troponin measurement on arrival, not serial measurements
  • Clinical factors include EKG changes, symptom characteristics, and hemodynamic status
  • Implementation has shown reduction in unnecessary hospital admissions
  • Superior performance compared to NICE guidelines for chest pain evaluation

Evidence & Literature Citations

  1. Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2017;34(6):349-356.
  2. Greenslade JH, Carlton EW, Van Hise C, et al. Diagnostic accuracy of the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid with a point-of-care cardiac troponin assay. Acad Emerg Med. 2020;27(6):459-466.

Score Interpretation Ranges

Very Low Risk0 – 0.02 pts

ACS ruled out

Low Risk0.02 – 0.05 pts

Low risk

Moderate Risk0.05 – 0.95 pts

Intermediate risk

High Risk0.95 – 1 pts

ACS ruled in

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.